GBIM — GlobeImmune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for GlobeImmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2011 December 31st	2012 December 31st	C2013 December 31st	2014 December 31st	2015 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-Q	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	15.2	2	5.92	16.8	9.9
Total Other Current Assets
Total Current Assets	15.6	2.89	6.83	17.8	11.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.07	1.25	0.493	0.456	0.21
Other Long Term Assets
Total Assets	17.7	4.24	7.42	18.4	11.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	13.4	8.35	6.41	5.17	4.23
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	37.5	25.6	19.1	12.8	8.52
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-19.8	-21.3	-11.6	5.6	2.99
Total Liabilities & Shareholders' Equity	17.7	4.24	7.42	18.4	11.5
Total Common Shares Outstanding